ADCT
Price
$2.70
Change
-$0.15 (-5.26%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
267.92M
47 days until earnings call
ANAB
Price
$23.37
Change
+$0.13 (+0.56%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
686.92M
46 days until earnings call
Interact to see
Advertisement

ADCT vs ANAB

Header iconADCT vs ANAB Comparison
Open Charts ADCT vs ANABBanner chart's image
ADC Therapeutics SA
Price$2.70
Change-$0.15 (-5.26%)
Volume$14.5K
Capitalization267.92M
AnaptysBio
Price$23.37
Change+$0.13 (+0.56%)
Volume$7.24K
Capitalization686.92M
ADCT vs ANAB Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. ANAB commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Buy and ANAB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ADCT: $2.70 vs. ANAB: $23.38)
Brand notoriety: ADCT and ANAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 200% vs. ANAB: 53%
Market capitalization -- ADCT: $267.92M vs. ANAB: $686.92M
ADCT [@Biotechnology] is valued at $267.92M. ANAB’s [@Biotechnology] market capitalization is $686.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileANAB’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • ANAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 5 TA indicator(s) are bullish while ANAB’s TA Score has 2 bullish TA indicator(s).

  • ADCT’s TA Score: 5 bullish, 4 bearish.
  • ANAB’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than ANAB.

Price Growth

ADCT (@Biotechnology) experienced а -10.89% price change this week, while ANAB (@Biotechnology) price change was -0.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ADCT is expected to report earnings on Aug 12, 2025.

ANAB is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANAB($687M) has a higher market cap than ADCT($268M). ANAB YTD gains are higher at: 76.586 vs. ADCT (35.678). ANAB has higher annual earnings (EBITDA): -76.35M vs. ADCT (-95.64M). ANAB has more cash in the bank: 340M vs. ADCT (195M). ANAB has less debt than ADCT: ANAB (15.6M) vs ADCT (123M). ANAB has higher revenues than ADCT: ANAB (112M) vs ADCT (75.8M).
ADCTANABADCT / ANAB
Capitalization268M687M39%
EBITDA-95.64M-76.35M125%
Gain YTD35.67876.58647%
P/E RatioN/AN/A-
Revenue75.8M112M68%
Total Cash195M340M57%
Total Debt123M15.6M788%
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
34

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTANAB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 21 days ago
78%
Bullish Trend 29 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAIIX18.00N/A
N/A
iShares MSCI EAFE Intl Idx Instl
IPMIX19.37N/A
N/A
Voya Index Plus MidCap Port I
GWSVX16.45N/A
N/A
Gabelli Focused Gr and Inc AAA
DUSQX33.41N/A
N/A
DFA US Large Cap Equity Institutional
VVSCX11.28N/A
N/A
VALIC Company I Small Cap Value

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
-2.17%
QTTB - ADCT
48%
Loosely correlated
-2.52%
VTYX - ADCT
44%
Loosely correlated
+2.08%
IMNM - ADCT
41%
Loosely correlated
+1.27%
OVID - ADCT
40%
Loosely correlated
+9.06%
CLRB - ADCT
40%
Loosely correlated
-7.05%
More

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with QTTB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
+0.60%
QTTB - ANAB
43%
Loosely correlated
-2.52%
ADCT - ANAB
38%
Loosely correlated
-2.17%
AMRN - ANAB
38%
Loosely correlated
-1.79%
CLRB - ANAB
37%
Loosely correlated
-7.05%
SPRY - ANAB
36%
Loosely correlated
+4.75%
More